Alphyn Biologics Secures $25M in Oversubscribed Series B to Enhance Dermatology Pipeline.
Amount Raised
$25 Million
Round Type
Series B
AnnapolisBiotechnologyHealthcareInvestors
Description
Alphyn Biologics, Inc. has closed its $25 million oversubscribed Series B financing round. The funds will support the Phase 2b clinical trial of Zabalafin Hydrogel for atopic dermatitis and initiate a Phase 2 program for molluscum contagiosum. The financing was led by QCA Investment Group, with participation from existing and new investors
Quick answer
Alphyn Biologics raised $25 Million in a Series B round, dated December 12, 2025. Investors: Angel Physicians Fund, Serial Stage Venture Partners and QCA Investment Group. Alphyn Biologics is based in Annapolis, Maryland, United States.
- How much did Alphyn Biologics raise?
- Alphyn Biologics raised $25 Million in a Series B round on December 12, 2025.
- Who invested in Alphyn Biologics?
- Angel Physicians Fund, Serial Stage Venture Partners and QCA Investment Group are named as investors in this round.
- What does Alphyn Biologics do?
- Alphyn Biologics is a clinical-stage dermatology company developing first-in-class multi-target therapeutics for severe and prevalent skin diseases based on its AB-101 platform.
- Where is Alphyn Biologics based and how big is it?
- Alphyn Biologics is based in Annapolis, Maryland, United States. Fundz records about 4 employees.
- Who are the decision-makers at Alphyn Biologics?
- Fundz holds 1 contact at Alphyn Biologics, including the President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Alphyn Biologics that raised within 45 days of this round, from Fundz verified event records.
- Ocugen raised $23M (Post-IPO Equity) on January 26, 2026.
- Novabay raised $134M on January 16, 2026.
- Os Therapies raised $3.5M on January 14, 2026.
- Route 92 Medical raised $50M on January 13, 2026.
- Tessera Defense & Homeland Security Inc. raised $3.3M on January 13, 2026.
- Parabilis Medicines raised $305M (Series F) on January 8, 2026.
Who to call at Alphyn Biologics, and when
A new round usually means Alphyn Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alphyn Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alphyn Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alphyn Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alphyn Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAlphyn Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.